Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cory R Weissman

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Brain Sciences|October 25, 2024
Developmental Predictors of Suicidality in Schizophrenia: A Systematic ReviewLindsay L Benster, Noah Stapper, Katie Rodriguez, et al.
Psychopharmacology|January 4, 2019
Microdosing psychedelics: personality, mental health, and creativity differences in microdosersThomas Anderson, Rotem Petranker, Daniel Rosenbaum, et al.
Acta Psychiatrica Scandinavica|February 21, 2022
Effect of high frequency versus theta-burst repetitive transcranial magnetic stimulation on suicidality in patients with treatment-resistant depressionShobha Mehta, Jonathan Downar, Benoit H Mulsant, et al.
Journal of Affective Disorders|June 24, 2026
Latent class modeling of repetitive transcranial magnetic stimulation response trajectories in treatment-resistant depressionCory R Weissman, Brian Cui, Lindsay Benster, et al.
Journal of Affective Disorders|June 8, 2026
Comparing transcranial magnetic stimulation and esketamine treatment response trajectories in resistant depressionLindsay L Benster, Jordan N Kohn, Benjamin Wade, et al.
Psychopharmacology|October 29, 2020
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trialRichard J Zeifman, Nikhita Singhal, Rafael G Dos Santos, et al.
Psychiatry Research|February 26, 2026
The use of repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), ketamine, and esketamine in reducing suicidality in major depressive disorder: A comprehensive narrative reviewTrisha Menon, Andy Lu, Akhilan Arulmozhi, et al.
The Journal of Clinical Psychiatry|April 28, 2018
Bilateral Repetitive Transcranial Magnetic Stimulation Decreases Suicidal Ideation in DepressionCory R Weissman, Daniel M Blumberger, Patrick E Brown, et al.
Translational Psychiatry|November 17, 2025
Neurophysiological biomarkers of treatment response in suicidal ideation: a systematic reviewNoah Stapper, Lindsay L Benster, Sahit Menon, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
A Systematic Review of Study Design and Placebo Controls in Psychedelic ResearchAlexander Wen, Nikhita Singhal, Brett D M Jones, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Brain Sciences|October 25, 2024
Developmental Predictors of Suicidality in Schizophrenia: A Systematic ReviewLindsay L Benster, Noah Stapper, Katie Rodriguez, et al.
Psychopharmacology|January 4, 2019
Microdosing psychedelics: personality, mental health, and creativity differences in microdosersThomas Anderson, Rotem Petranker, Daniel Rosenbaum, et al.
Acta Psychiatrica Scandinavica|February 21, 2022
Effect of high frequency versus theta-burst repetitive transcranial magnetic stimulation on suicidality in patients with treatment-resistant depressionShobha Mehta, Jonathan Downar, Benoit H Mulsant, et al.
Journal of Affective Disorders|June 24, 2026
Latent class modeling of repetitive transcranial magnetic stimulation response trajectories in treatment-resistant depressionCory R Weissman, Brian Cui, Lindsay Benster, et al.
Journal of Affective Disorders|June 8, 2026
Comparing transcranial magnetic stimulation and esketamine treatment response trajectories in resistant depressionLindsay L Benster, Jordan N Kohn, Benjamin Wade, et al.
Psychopharmacology|October 29, 2020
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trialRichard J Zeifman, Nikhita Singhal, Rafael G Dos Santos, et al.
Psychiatry Research|February 26, 2026
The use of repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), ketamine, and esketamine in reducing suicidality in major depressive disorder: A comprehensive narrative reviewTrisha Menon, Andy Lu, Akhilan Arulmozhi, et al.
The Journal of Clinical Psychiatry|April 28, 2018
Bilateral Repetitive Transcranial Magnetic Stimulation Decreases Suicidal Ideation in DepressionCory R Weissman, Daniel M Blumberger, Patrick E Brown, et al.
Translational Psychiatry|November 17, 2025
Neurophysiological biomarkers of treatment response in suicidal ideation: a systematic reviewNoah Stapper, Lindsay L Benster, Sahit Menon, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
A Systematic Review of Study Design and Placebo Controls in Psychedelic ResearchAlexander Wen, Nikhita Singhal, Brett D M Jones, et al.
Pageof 3